| Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers H Rajak, P Kumar Dewangan, V Patel, D Kumar Jain, A Singh, ... Current pharmaceutical design 19 (10), 1923-1955, 2013 | 85 | 2013 |
| Novel limonene and citral based 2, 5-disubstituted-1, 3, 4-oxadiazoles: A natural product coupled approach to semicarbazones for antiepileptic activity H Rajak, BS Thakur, A Singh, K Raghuvanshi, AK Sah, R Veerasamy, ... Bioorganic & medicinal chemistry letters 23 (3), 864-868, 2013 | 70 | 2013 |
| Phytochemical screening and antimicrobial assessment of leaves of Adhatoda vasica, Azadirachta indica and Datura stramonium AK Gupta, NK Ahirwar, N Shinde, M Choudhary, YS Rajput, A Singh UK Journal of Pharmaceutical and Biosciences 1 (1), 42-47, 2013 | 68 | 2013 |
| Ebola virus disease: past, present and future H Rajak, DK Jain, A Singh, AK Sharma, A Dixit Asian Pacific Journal of Tropical Biomedicine 5 (5), 337-343, 2015 | 64 | 2015 |
| A structural insight into hydroxamic acid based histone deacetylase inhibitors for the presence of anticancer activity H Rajak, A Singh, K Raghuwanshi, R Kumar, PK Dewangan, ... Current medicinal chemistry 21 (23), 2642-2664, 2014 | 60 | 2014 |
| Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects A Singh, VK Patel, DK Jain, P Patel, H Rajak Oncology and Therapy 4 (1), 73-89, 2016 | 37 | 2016 |
| Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity H Rajak, A Singh, P K Dewangan, V Patel, D K Jain, S K Tiwari, ... Current medicinal chemistry 20 (14), 1887-1903, 2013 | 36 | 2013 |
| The safety, efficacy and therapeutic potential of histone deacetylase inhibitors with special reference to panobinostat in gastrointestinal tumors: A Review of Preclinical and … A Singh, P Patel, VK Patel, DK Jain, M Kamal, H Rajak Current cancer drug targets 18 (8), 720-736, 2018 | 25 | 2018 |
| Pharmacophore based 3D-qsar, virtual screening and docking studies on novel series of HDAC inhibitors with thiophen linker as anticancer agents P Patel, A Singh, V K Patel, D K Jain, R Veerasamy, H Rajak Combinatorial chemistry & high throughput screening 19 (9), 735-751, 2016 | 20 | 2016 |
| Assessment of 5-substituted Isatin as Surface Recognition Group: Design, Synthesis, and Antiproliferative Evaluation of Hydroxamates as Novel Histone Deacetylase Inhibitors ASKRVKPDKJRVADHRE author Pharmaceutical Chemistry Journal 51 (5), 366-374, 2017 | 18 | 2017 |
| Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects A Singh, P Patel, V K Patel, D K Jain, R Veerasamy, P C Sharma, H Rajak Current cancer drug targets 17 (5), 456-466, 2017 | 18 | 2017 |
| Development of Structure Activity Correlation Model on Azetidin-2-ones as Tubulin Polymerization Inhibitors V Kumar Patel, K Singh Chouhan, A Singh, D Kumar Jain, R Veerasamy, ... Letters in Drug Design & Discovery 12 (5), 351-365, 2015 | 16 | 2015 |
| Hydroxamic acid based Histone Deacetylase inhibitors: Present and future prospectives as anticancer agent DK Jain, A Singh, VK Patel, PC Sharma, A Gupta, A Sharma, H Rajak Int J Pharm Pharm Sci 6 (4), 648-50, 2014 | 16 | 2014 |
| Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studies HR Vijay K. Patel, Avineesh Singh, Deepak K. Jain, Preeti Patel ... Future Journal of Pharmaceutical Sciences, 2017 | 14 | 2017 |
| Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies A Singh, VK Patel, H Rajak Journal of Molecular Structure 1240, 130590, 2021 | 13 | 2021 |
| Development of Structure Activity Correlation Model on 4-Quinolones Derivatives as Tubulin Polymerization Inhibitors: Rationale to Advance the Understanding of Structure … VK Patel, A Singh, DK Jain, AK Sharma, AK Gupta, PC Sharma, H Rajak Drug Discov Dev 1, 1-16, 2014 | 11* | 2014 |
| Drug design strategies for the discovery of novel anticonvulsants concerned with four site binding pharmacophoric model studies D K Jain, A Singh, V K Patel, R Veerasamy, N Aggarwal, H Rajak Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2017 | 10 | 2017 |
| Development & evaluation of antipyretic &antinociceptive activity of polyherbal formulation containing some indigenous medicinal plants RK Sahu, A Singh, R Gupta, A Roy, J Dwivedi Int j of pharmacol 8 (4), 271-276, 2012 | 8 | 2012 |
| Development of Stability Indicating RP-HPLC Method for Ertapenem in Bulk Drug and Pharmaceutical Dosage Form R Jain, N Jain, DK Jain, A Singh, SK Jain Dhaka University Journal of Pharmaceutical Sciences 16 (1), 21-28, 2017 | 5 | 2017 |
| Novel Pyrimidine based Semicarbazones: Confirmation of Four Binding Site Pharmacophoric Model Hypothesis for Antiepileptic Activity H Rajak, D K Jain, S Singh, A Singh, V K Patel, R Veerasamy, R S Pawar Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2017 | 3 | 2017 |
